Cellevolve Launches with Acclaimed Investors and Pivotal Manufacturing Partnership, Focused on Accelerating the Commercialization of Novel Cell Therapies

SAN FRANCISCO--(BUSINESS WIRE)--Cellevolve Bio (“the Company” or “Cellevolve”), a development and commercialization company focused on cell therapies, today announced its launch following the successful close of seed financing and an exclusive manufacturing partnership with National Resilience, Inc. (Resilience), a biopharmaceutical manufacturing company supply. Founded and led by CEO Derrell Porter,...

Click to view original post